Terms: = Endocrine gland cancer AND NDRG1, NDR1, 10397, ENSG00000104419, Q92597, RIT42, CMT4D, TARG1, HMSNL, GC4, RTP, TDD5, PROXY1, NMSL, CAP43 AND Treatment
12 results:
1. ndrg1 overcomes resistance to immunotherapy of pancreatic ductal adenocarcinoma through inhibiting ATG9A-dependent degradation of MHC-1.
Zhang Z; Song B; Wei H; Liu Y; Zhang W; Yang Y; Sun B
Drug Resist Updat; 2024 Mar; 73():101040. PubMed ID: 38228036
[TBL] [Abstract] [Full Text] [Related]
2. Breaking the cycle: Targeting of ndrg1 to inhibit bi-directional oncogenic cross-talk between pancreatic cancer and stroma.
Geleta B; Park KC; Jansson PJ; Sahni S; Maleki S; Xu Z; Murakami T; Pajic M; Apte MV; Richardson DR; Kovacevic Z
FASEB J; 2021 Feb; 35(2):e21347. PubMed ID: 33484481
[TBL] [Abstract] [Full Text] [Related]
3. ndrg1 suppresses basal and hypoxia-induced autophagy at both the initiation and degradation stages and sensitizes pancreatic cancer cells to lysosomal membrane permeabilization.
Sahni S; Gillson J; Park KC; Chiang S; Leck LYW; Jansson PJ; Richardson DR
Biochim Biophys Acta Gen Subj; 2020 Aug; 1864(8):129625. PubMed ID: 32335136
[TBL] [Abstract] [Full Text] [Related]
4. The novel dithiocarbamate, DpdtC suppresses HER2-overexpressed cancer cells by up-regulating ndrg1 via inactivation of HER2-ERK 1/2 signaling.
Yang Y; Liu Y; Guo R; Fu Y; Zhang Z; Zhang P; Zhou P; Wang T; Huang T; Li X; Li C
Sci Rep; 2018 Feb; 8(1):3398. PubMed ID: 29467385
[TBL] [Abstract] [Full Text] [Related]
5. Role of metastasis-associated lung adenocarcinoma transcript-1 (MALAT-1) in pancreatic cancer.
Cheng Y; Imanirad P; Jutooru I; Hedrick E; Jin UH; Rodrigues Hoffman A; Leal de Araujo J; Morpurgo B; Golovko A; Safe S
PLoS One; 2018; 13(2):e0192264. PubMed ID: 29389953
[TBL] [Abstract] [Full Text] [Related]
6. Histone Deacetylase Inhibition Restores Expression of Hypoxia-Inducible Protein ndrg1 in Pancreatic cancer.
Tiffon C
Pancreas; 2018 Feb; 47(2):200-207. PubMed ID: 29303911
[TBL] [Abstract] [Full Text] [Related]
7. Identification of ovarian cancer subtype-specific network modules and candidate drivers through an integrative genomics approach.
Zhang D; Chen P; Zheng CH; Xia J
Oncotarget; 2016 Jan; 7(4):4298-309. PubMed ID: 26735889
[TBL] [Abstract] [Full Text] [Related]
8. The Metastasis Suppressor, N-MYC Downstream-regulated Gene-1 (ndrg1), Down-regulates the ErbB Family of Receptors to Inhibit Downstream Oncogenic Signaling Pathways.
Kovacevic Z; Menezes SV; Sahni S; Kalinowski DS; Bae DH; Lane DJ; Richardson DR
J Biol Chem; 2016 Jan; 291(3):1029-52. PubMed ID: 26534963
[TBL] [Abstract] [Full Text] [Related]
9. The silencing of N-myc downstream-regulated gene-1 in an orthotopic pancreatic cancer model leads to more aggressive tumor growth and metastases.
Kim-Fuchs C; Winterhalder S; Winter A; Malinka T; Born D; Schäfer S; Stroka D; Gloor B; Candinas D; Angst E
Dig Surg; 2014; 31(2):135-42. PubMed ID: 24970329
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic value of gross tumor volume delineated by FDG-PET-CT based radiotherapy treatment planning in patients with locally advanced pancreatic cancer treated with chemoradiotherapy.
Parlak C; Topkan E; Onal C; Reyhan M; Selek U
Radiat Oncol; 2012 Mar; 7():37. PubMed ID: 22429939
[TBL] [Abstract] [Full Text] [Related]
11. Epigenetic regulation affects N-myc downstream-regulated gene 1 expression indirectly in pancreatic cancer cells.
Angst E; Dawson DW; Nguyen A; Park J; Go VL; Reber HA; Hines OJ; Eibl G
Pancreas; 2010 Jul; 39(5):675-9. PubMed ID: 20173668
[TBL] [Abstract] [Full Text] [Related]
12. Dummy run for a phase II multi-institute trial of chemoradiotherapy for unresectable pancreatic cancer: inter-observer variance in contour delineation.
Yamazaki H; Nishiyama K; Tanaka E; Koiwai K; Shikama N; Ito Y; Arahira S; Tamamoto T; Shibata T; Tamaki Y; Kodaira T; Oguchi M
Anticancer Res; 2007; 27(4C):2965-71. PubMed ID: 17695480
[TBL] [Abstract] [Full Text] [Related]
